June 2014
Recent News Clips
06/02/2014 Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer Trial results showed a near doubling of the length of time during and after treatment that the cancer did not get worse.5/22/2014 Inclusion Reporting Expands to Progress Reports There is an updated format for providing sex/gender, race, and ethnicity information in progress reports for clinical research studies.
5/19/2014 Personalized Immunotherapy Treats Epithelial Cancer from NIH Research Matters - A new treatment uses a patient's own immune system to attack tumor cells. The approach may be used to treat many common cancers.
5/14/2014 NIH Takes Steps to Address Sex Differences in Preclinical Research NIH steps to address sex differences in preclinical research.
NCI Standard Funding Opportunity Announcements | |||||||||||||||||||||||||||||||||||||||
| Current and Recent Program Announcements | Current and Recent Requests for Applications | |||||||||||||||||||||||||||||||||||||||
| Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals | Standard Due Dates | |||||||||||||||||||||||||||||||||||||||
 |
|
||||||||||||||||||||||||||||||||||||||
Peer Reviewed Cancer Research Program (PRCRP)
Supports impactful research projects with an emphasis on discovery. |
|||||||||||||||||||||||||||||||||||||||
| Due Date | June 10 - Pre-applications
Invited Applications: September 18 (OSR) | September 22 (Sponsor) |
| Amount & Project Period: | $360,000 (Direct Costs) - 3 years |
| Eligibility: | Applicants must be within 7 years of first faculty appointment and have a minimum of 30% protected time for proposed research. |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | W81XWH-14-PRCRP-CDA |
| June 10 (Pre-app) | Jr. Faculty | Federal | Special Focus Ideas |
PRCRP Idea Award with Special Focus
To be considered for funding, applications for the PRCRP Idea Award with Special Focus must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.| Due Date | June 10: Pre-applications Invited Applications: September 15 (OSR) | September 17 (Sponsor) |
| Amount & Project Period: | $300,000 direct costs over 2 years |
| Eligibility: | Jr. Faculty at or above Assistant
Professor |
| Contact: |
Linda Nolan,
x6071 |
| RFA Link: | W81XWH-14-PRCRP-IA |
New
| June 12 (Pre-app) | All Faculty | Federal | Prostate Cancer |
Prostate Cancer Research
Program (PCRP)
Synergistic Idea Development Award
Supports new ideas representing innovative approaches to prostate
cancer research involving 2 or 3 independent, faculty-level (or
equivalent) PIs utilizing their complementary and synergistic perspectives
to address a central problem or question in prostate cancer research.
Designed to support new and pre-existing partnerships| Due Date | June 12 (Pre-application) Invited Applications: September 22 (OSR) | September 24 (Sponsor) |
| Amount & Project Period: | $750,000 (Direct
Costs) - 3 years |
| Eligibility: | At or above Assistant Professor |
| Contact: |
Linda Nolan
(x6071) |
| RFA Link: | W81XWH-14-PCRP-SIDA |
New
| June 12 (Pre-app) | All Faculty | Federal | Prostate |
Prostate Cancer Research Program (PCRP)
Idea Development Award
Supports new ideas representing innovative approaches to prostate
cancer research Presentation of preliminary data is encouraged but
not required.| Due Date | June 18 (Pre-application)
Invited Applications: September 22 (OSR) | September 24 (Sponsor) |
| Amount & Project Period: | 3 year performance period Established Investigators: $375,000 (Direct Costs) New Investigators: $225,000 (Direct Costs) |
| Eligibility: | All Faculty |
| Contact: |
Linda Nolan
(x6071) |
| RFA Link: | W81XWH-14-PCRP-IDA |
| June 12 (OSR)
June 16 (Sponsor) |
Grad students/Postdocs/
Fellows/Med Students/Nurse Researchers |
Non-federal | Lung Cancer |
Lung Cancer Research Foundation Award
The Lung Cancer Research Foundation welcomes submissions of grant requests for medical/scientific research projects covering all aspects of lung cancer research. Grant requests can include new project submissions, as well as requests for renewal of current funding.| Due Date | June 12 - OSR June 16 - Sponsor |
| Amount & Project Period: | $50,000 - 1 year |
| Eligibility: | Graduate Students, postdoctoral researchers, physicians, medical students, & nurse researchers |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | LCRF 2014 Grants |
| June
11 (OSR) June 13 (Sponsor) |
All Faculty | Non-federal | Disparities Research |
The A. David Mazzone Research Awards Program
Disparity Research Awards
To address prostate cancer disparities as differences in the incidence,
prevalence, mortality, and burden of prostate cancer and related
adverse health conditions on specific population groups Focus on
factors that contribute to prostate cancer disparities including
interactions of the social and physical environment, behavioral
factors, and/or biologic/molecular pathways.
| Due Date: | June 11 (OSR) | June 13 (Sponsor) |
| Amount & Project Period:
|
$35,000/year (Direct Costs) - 2 years |
| Eligibility: |
Two or more independent investigators, at least one of whom holds a full-time Harvard faculty appointment at the level of Instructor or higher. |
| Contact: |
Linda Nolan, x6071 |
| RFA Link: | Disparity Research Award |
| June 16 (LOI) | HOPA Members | Non-federal | Hematology/Oncology |
The Hematology/Oncology Pharmacy Association (HOPA) Foundation 2014 Research Fund Award
To facilitate the efforts of hematology/oncology pharmacists working to optimize the care of individuals affected by cancer.| Due Date | June 16 - Letter of Intent
Invited Applications: September 11 (OSR) | September 15 (Sponsor) |
| Amount & Project Period: | $50,000 total for 1 year |
| Eligibility: | HOPA Members only |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | 2014 HOPA Research Fund Award |
| June 18 (Pre-app.) | All Faculty | Federal | Biomarker Development |
Prostate Cancer Research Program (PCRP)
Biomarker Development Award
High-impact research aimed at multi-institutional validation and/or
qualification of prostate cancer biomarkers for crucial decision
making in prostate cancer management, including detection of aggressive
disease, prognosis and progression, and prediction and assessment
of response to therapy.| Due Date | June 18 (Pre-application)
Invited Applications: September 22 (OSR) | September 24 (Sponsor) |
| Amount & Project Period: | $2,250,000 (Direct Costs) - 3 years |
| Eligibility: | Applications are required to
be multi-institutional in approaches to large-scale
biomarker validation or qualification. Each PI (Initiating and Partnering) must be at or above Assistant Professor. |
| Contact: |
Linda Nolan
(X6071) |
| RFA Link: | W81XWH-14-PCRP-BDA |
| U01 | NIH |
| June 17 - OSR June 19 - Sponsor |
All Faculty | Federal | Big Data |
Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need
Development of innovative analytical methods and software tools with the objective of addressing current & emerging needs for using, managing, and analyzing the larger and more complex data sets inherent to biomedical Big Data. FOA has 4 focus areas: Data Compression/Reduction, Data Visualization, Data Provenance & Data Wrangling.| Due Date: | June 17 (OSR) | June 19 (Sponsor) |
| Amount & Project Period: | $300,000/year (Direct Costs) - 3 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | RFA-HG-14-020 |
New
| June 20 (LOI) | All Ranks | Federal | PCOR |
Disseminating and Implementing Evidence from Patient-Centered Outcomes Research in Clinical Practice Using Mobile Health Technology (R21)
To develop and evaluate the effectiveness of novel approaches that use mHealth tools to enable timely incorporation and appropriate use of PCOR evidence in clinical practice| Due Date | June 20 (Letter of Intent)
Applications Due: July 31 (OSR) | August 4 (Sponsor) |
| Amount & Project Period: | $300,000 (TOTAL COSTS) - 2 years |
| Eligibility: | All Ranks - PD/PI expected to contribute
a minimum of 15% annual effort each year of grant. Only
one PD/PI may be designated on the application. |
| Contact: |
Linda Nolan
(X6071) |
| RFA Link: | RFA-HS-14-010 |
| R01/R21 | NIH |
| June 18 - OSR June 20 - Sponsor |
All Faculty | Federal | Provocative Cancer Questions |
Research Answers to NCI's Provocative Questions
Innovative research projects designed to solve specific problems and paradoxes in cancer research. This is the final submission date for these RFAs.| Due Date: | June 18 (OSR) | June 20 (Sponsor) |
| Amount & Project Period: | R01 - Unlimited funding - 4 years
R21 - $275,000 (Direct Costs) - 2 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan, x6071 |
| RFA Links and related topics for all groups: | Group A - relates to investigation
of changes in behavior & exposure risks, mechanistic
links between cancer risk factors and biological events
associated with cancer development. RFA-CA-13-016 (R01) | RFA-CA-13-017 (R21) Group B - Relates to mechanisms of tumor development or recurrence. RFA-CA-13-018 (R01) | RFA-CA-13-019 (R21) Group C - Relates to cancer detection, diagnosis, and prognosis. RFA-CA-13-020 (R01) | RFA-CA-13-021 (R21) Group D - Relates to cancer therapy. RFA-CA-13-022 (R01) | RFA-CA-13-023 (R21) Group E - Relates to clinical effectiveness. RFA-CA-13-024 (R01) | RFA-CA-13-025 (R21) |
New
| June 25 | All Ranks | Federal | Prostate |
Prostate Cancer Research Program Exploration Hypothesis Development Award
Supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described.| Due Date: | June 25 (Pre-application) July 7 (OSR) | July 09 (Sponsor) |
| Amount & Project Period: | $75,000 (direct Costs) - 1 year |
| Eligibility: | All investigators at or above postdoctoral
fellow (or equivalent) are eligible. |
| Contact: |
Linda Nolan
(X6071) |
| RFA Link: | W81XWH-14-PCRP-EHDA |
| June 27 (LOI) | All Faculty | Non-Federal | PCO Evaluations |
Large Pragmatic Studies to Evaluate Patient-Centered Outcomes
Eligible studies compare two or more alternatives for addressing prevention, diagnosis, treatment, or management of a disease or symptom; improving health care system-level approaches to managing care; or eliminating health or healthcare disparities.| Due Date: | June 27 - Letter of Intent
Invited Applications: October 31 (OSR) | November 4 (Sponsor) |
| Amount & Project Period: | $10,000,000 direct
costs over 5 years |
| Eligibility: | All Faculty |
| Contact: |
Linda Nolan,
x6071 |
| PA Links: |
Announcement |
Funding Center |
New
| June 29 (LOI) | All Ranks | Federal | Disparities Research |
NLM Information Resource Grants to Reduce Health Disparities (G08)
Projects that will bring useful, usable health information to health disparity populations and their health care providers. A G08 grant is available to health-related institutions to improve the organization and management of health related information using computers and networks.| Due Date | June 29 (Letter of Intent) Applications Due: July 25 (OSR) | July 29 (Sponsor) |
| Amount & Project Period: | $100,000 - 1 year, $200,000 - 2 years or $300,000 - 3 years No F&A allowed |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| RFA Link: | RFA-LM-14-001 |
| June 26 (OSR) June 30 (Sponsor) |
MD, PhD or MD/PhD | Non-Federal | Leukemia |
Children's Leukemia Research Association, Inc.
Seeks to fund research grants for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.| Due Date | October 31 - (OSR) | November 4 - (Sponsor) |
| Amount & Project Period: | $30,000 total for 1 year |
| Eligibility: | MDs, PhDs or MD/PhDs conducting leukemia research. |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | CLRA Research Grants |
| June 26 (OSR) June 30 (Sponsor) |
Clinical Faculty | Non-federal | Nintedanib |
Phase I/II Clinical Trials and Correlative Studies of Nintedanib for Selected Solid Tumors
Proposed clinical trials should focus on developing feasible studies of Nintedanib with particular emphasis on lung and gastrointestinal cancers. Clinical trials in other areas will be considered if supported by a strong mechanistic rationale.| Due Date | June 26 (OSR) | June 30 (Sponsor) |
| Amount & Project Period: | 2 years Phase I and Single-arm,
Phase II clinical trials: $300,000 (total costs
include direct costs and 25% indirect costs) per trial.
The Correlative Laboratory studies section of the clinical trial will be funded up to a total cost of $100,000, including up to 25% indirect costs |
| Eligibility: | Clinical Faculty |
| Contact: | Linda Nolan (X6071) |
| RFA Link: | Phase I/II Clinical Trials and Correlative Trials of Nintedanib for Selected Solid Tumors |
| U01 | NIH |
New
| June 26 (OSR) June 29 (Sponsor) |
All Ranks | Federal | Mathematical Modeling |
Development of an Integrated Mathematical Model for Comparative Characterization of Complex Molecules
A mathematical algorithm or model, integrating in vitro chemical and biological characterization data based on an orthogonal set of high-resolution characterization methods will be developed to provide a coherent picture of the structure for the complex molecules| Due Date | June 26 (OSR) │ June 29 (Sponsor) |
| Amount & Project Period: | $600,000 (Total Costs) - 1 year |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| RFA Link: | RFA-FD-14-082 |
New
| June 27 (OSR) July 1 (Sponsor) |
Jr. Faculty Clinical Fellows |
Non-Federal | Basic or Trans/Clin Res |
Damon Runyon-Rachleff Innovation Award
Specifically designed to provide funding to extraordinary early career researchers with an innovative new idea but without sufficient preliminary data to obtain traditional funding. Research must be novel and have strong potential for high impact in the cancer field.| Due Date | June 27 - OSR | July 1 - Sponsor |
| Amount & Project Period: | $150,000/year for 3 years |
| Eligibility: | Applicants must belong to one of
the following categories: 1. Tenure-track Assistant Professors within 4 years of initial Assistant Professor position. (Cut-off date: July 1, 2010.) 2. Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding MD and pursuing a period of independent research before taking a tenure-track faculty position. Must have an exceptional record of research accomplishment, dedicated laboratory space and the support of institution. 3. Must have 80% protected time for research 4. Non-citizens may apply |
| Contact: | Linda Nolan, x6071 |
| Links: | Innovation Award Overview | Application Guidelines |
| June 27 (OSR) July 1 (Sponsor) |
Postdocs | Non-Federal | Biomedical Science |
The Helen Hay Whitney Foundation
Supports early postdoctoral research training in all basic biomedical sciences.| Due Date | June 27 - OSR | July 1 - Sponsor |
| Amount & Project Period: | Year 1 - $49,000 Year 2 - $50,000 Year 3 - $51,000 |
| Eligibility: | US citizen postdocs with no more than 1 year training at time of application. |
| Contact: | Linda Nolan, x6071 |
| Link: | HHWF Postdoctoral Fellowship |
in collaboration
with the Marcus
Foundation
New
| June 30 (LOI) | All Faculty | Non-federal | Prostate Cancer |
Intravenous Vitamin C Therapy for Prostate Cancer Patients
Pilot award for a project that will investigate the mechanisms and potential for intravenous vitamin C therapy in the treatment of advanced prostate cancer and mitigation of chemotherapy associated toxicity.| Due Date | June 30 (Letter of Intent) |
| Amount & Project Period: | $100,000 - 1 year |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (X6071) |
| Letter of Intent Submission information: | Please submit a 2-page LOI that
contains: • Research Strategy and Objectives; • Impact; and • Personnel The LOI should include your name, email address and phone number at top of first page. Please email a PDF of the LOI to applications@pcf.org. A select number of applicants will be invited by PCF to submit full five-page applications for this award. |
New
| June 30 | All Ranks | Non-federal | Nintedanib |
National Comprehensive Cancer Network (NCCN)
Phase I/II Clinical Trials and Correlative Trials of Nintedanib
for Selected Solid Tumors
Proposed clinical trials should focus on developing feasible studies
of nintedanib w/a particular emphasis on lung and gastrointestinal
(including gastric, pancreatic, neuroendocrine and colorectal) cancers.
Clinical trials in other areas will be considered if supported by
a strong mechanistic rationale.| Due Date | June 26 (OSR) | June 30 (Sponsor) |
| Amount & Project Period: | 2 years Phase I and Single-arm, Phase II clinical trials: $300,000 (total costs including direct costs and 25% indirect costs) per trial. The Correlative Laboratory studies section of the clinical trial will be funded up to a total cost of $100,000, including up to 25% indirect costs |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| RFA Link: | Phase I/II Clinical Trials and Correlative Trials of Nintedanib for Selected Solid Tumors |
| U01 | NCI |
| June 8 (LOI) July 3 (OSR) July 8 (Sponsor) |
All Faculty | Federal | Cancer Epidemiology |
Core Infrastructure & Methodological Research for Cancer Epi Cohorts
Support for infrastructure and core functions for existing or new Cancer Epidemiology Cohorts (CECs).| Due Date | June 8 - Letter of intent
Applications Due: July 3 - OSR | July 8 - Sponsor |
| Amount & Project Period: | Budget not limited for 5 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | PAR-14-160 |
New (4)
| July 10 (Pre-app.) | All Ranks | Federal | Neurofibromatosis |
Neurofibromatosis Research Program (NFRP)
New Investigator Award
Supports development of independent investigators and/or transition
of established investigators into a career in NF research. Experience
in NF research not required. Preliminary or published data required
Clinical trials not allowed.| Due Date (All NFRP Initiatives below) | July 10 (Pre-application) Applications Due: July 22 (OSR) | July 24 (Sponsor) |
| Amount & Project Period: | $400,000 (Direct Costs) - 4 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| PA Link: |
W81XWH-14-NFRP-NIA |
Neurofibromatosis Research Program (NFRP)
Investigator-initiated Research Award
Supports highly rigorous, high-impact research with potential to
make an important contribution to NF research and/or patient care.
Preliminary or published data required. Optional Qualified Collaborator:
Applications that include a Qualified Collaborator meeting criteria
identified in the Program Announcement may apply for a higher level
of funding. Clinical trials not allowed.| Amount & Project Period: | $525,000 (Direct Costs) $575,000 if incl. Optional Qualified Collaborator - 3 years |
| Eligibility: | All Ranks |
| Contact: |
Linda Nolan
(x6071) |
| PA Link: | W81XWH-14-NFRP-IIRA |
Neurofibromatosis Research Program (NFRP)
Exploration Hypothesis Development Award
Supports initial exploration of innovative, high-risk, high-gain
concepts in NF research laying groundwork for future avenues of
investigation. Preliminary or published data encouraged but not
required. Clinical trials not allowed. | Amount & Project Period: | $100,000 (Direct Costs) - 2 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| PA Link: | W81XWH-14-NFRP-EHDA |
Neurofibromatosis Research Program (NFRP)
Clinical Trial Award
The CTA funds Phase 0, I, or II clinical trials relevant to NF and/or
schwannomatosis. Combinations of phases are permitted. Scientific
rationale and/or preliminary data are required for pilot trials
and for Phase I, II trials.| Amount & Project Period: | $900,000 (Direct Costs) - 4 years |
| Eligibility: | Established Investigators (Independent at or above Assistant Professor) |
| Contact: | Linda Nolan (x6071) |
| PA Link: | W81XWH-14-NFRP-CTA |
New
| July 15 | All Faculty Ranks | Internal Funding | Clinical Trials |
Moffitt Clinical Trial Funding Opportunity - Cycle II
Emphasis on increasing minority accrual and utilization of Total Cancer Care. Funding will be awarded to a proposal for an investigator-initiated phase 0, I, or II therapeutic or supportive care clinical trial that addresses an underrepresented population and is likely to lead to increased minority subject accrual.| Due Date | July 15 (as a PDF file to Maureen Ahearn (x8824) |
| Amount & Project Period: | $100,000 for the clinical trial (including trial coordination, data management, non-billable lab tests, etc.) and up to $50,000 for correlative science costs (including shared resources, research lab supplies and tech support). |
| Eligibility: | All Faculty Ranks |
| Contact: | Maureen Ahearn (x8824) |
| RFA Link: | RFP Clinical Trial Funding Opportunity |
New
| Jul. 23 (Pre-app.) | Established Investigators | Federal | Biospecimen Resource Site |
Prostate Cancer Research Program Prostate Cancer Biospecimen Resource Site Award
to expand the PCBN by adding Resource Sites that will enhance the biorepository's utility to prostate cancer researchers through the provision of biospecimens that are unique and/or in limited supply.| Due Date | July 23 (Pre-application) Invited Submissions: October 27 (OSR) | October 29 (Sponsor) |
| Amount & Project Period: | $200,000/year (Direct Costs) - 2 years |
| Eligibility: | Established Investigators |
| Contact: |
Linda Nolan
(X6071) |
| PA Link: | W81XWH-14-PCRP-PCBRSA |
| Jul 23 (Pre-app.) | Established Investigators | Federal | Pre-clinical Studies |
Prostate Cancer Research Program
Laboratory - Clinical Transition Award
Supports product-driven preclinical studies of promising lead agents
or medical devices that have the potential to revolutionize prostate
cancer clinical care.| Due Dates: | July 23 (pre-application) Invited Submissions: October 27 (OSR) | October 29 (Sponsor) |
| Amount & Project Period: | $500,000/year (Direct Costs) - 3 years |
| Eligibility: | Established Investigators |
| Contact: |
Linda Nolan
(x6071) |
| PA Link: |
W81XWH-14-PCRP-LCTA |
| Jul. 23 (Pre-app) | All Faculty | Federal | Health Disparities |
Prostate Cancer Research Program
Dr. Barbara Terry-Koroma Health Disparity Research Award
Supports new ideas based on innovative concepts or methodologies
for health disparity research with the potential to make an important
contribution toward eliminating death from prostate cancer and enhancing
the well-being of men impacted by the disease. Applicants for this
award must explicitly state how the proposed research is related
to an area of prostate cancer health disparity.| Due Date | July 23 (Pre-application) Invited Submissions: September 22 (OSR) | September 24 (Sponsor) |
| Amount & Project Period: | $350,000 (Direct Costs) - 3 years
(New & Established Investigators $600,000 (Direct Costs - 3 years (If using Qualified Collaborator Option) Additional $92,500 (if using Nested Health Disparity Traineeship Option for Pre-doctoral trainee) Additional $115,000 (if using Nested Health Disparity Traineeship Option for postdoctoral trainee) |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (X6071) |
| RFA Link: |
W81XWH-14-PCRP-HDRA |
| Jul. 23 (Pre-app.) | All Faculty | Federal | Prostate (Clinical) |
Prostate Cancer Research Program Clinical Exploration Award
Supports clinical trials encompassing Phase 0, Phase I, or pilot Phase II for drugs or drug combinations, Class II or III for devices, or other types of trials conducting early clinical testing of innovative approaches for prostate cancer. Also supports innovative, hypothesis-based, correlative studies that derive from ongoing or completed clinical trials supported by other funding sources.| Due Date | July 23 (Pre-application)
Invited Submissions: October 27 (OSR) | October 29 (Sponsor) |
| Amount & Project Period: | $450,000 (Direct Costs) - 5 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (x6071) |
| PA Link: | W81XWH-14-PCRP-CEA |
| Jul. 28 | Postdocs | Non-Federal | Career Development |
Stand Up To Cancer-Cancer Research UK Translational Research Fellowship
Translational research addressing critical problems in cancers with potential to deliver patient benefit.| Due Date | July 24 - (OSR) | July 28 - (Sponsor) |
| Amount & Project Period: | $315,000 total costs for 4 years |
| Eligibility: | Open to US and UK-based individuals holding a PhD and/or a US medical degree and have less than 2 years of postdoctoral or clinical research experience. Must identify 1 qualified US host laboratory and mentor, and 1 qualified UK host laboratory and mentor. Work must be performed in 2 phases: 1 in the United States and 1 in the United Kingdom. |
| Contact: | Linda Nolan, x6071 |
| RFA Link: |
SU2C Funding Opportunities - AACR Cancer Research UK Program Guidelines |
| T32 | NIH |
| June 24 (LOI) July 24 (OSR) July 28 (Sponsor) |
Established Faculty |
Federal | Big Science Training |
Pre-doctoral Training in Biomedical Big Data Science
This pre-doctoral training initiative:1. Requires trainees to work effectively at the intersection of computer science/informatics, statistics/mathematics, and biomedical science;
2. Expects active participation of training faculty from all 3 of these scientific disciplines working collaboratively as co-mentors of trainees in Big Data Science; and
3. Develops skills required to participate in a team approach to solving data-intensive biomedical problems.
Due Date |
June 24 - Letter of Intent Applications Due: July 24 (OSR) | July 28 (Sponsor) |
| Amount & Project Period: | Approximately $350,000 total costs over 5 year. |
| Eligibility: | Established Investigators in areas relevant to biomedical Big Science Data. |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | RFA-HG-14-004 |
| R01 | NIMHD |
New
| Jul 28 (LOI) | All Ranks | Federal | Health Disparities |
Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01)
Basic and applied research on fundamental biological mechanisms involved in disease conditions that disproportionately affect health disparity populations and therapies, or interventions that can directly or demonstrably contribute to reducing or eliminating health disparities.| Due Date | July 28 (Letter of Intent)
Applications Due: August 26 (OSR) | August 28 (Sponsor) |
| Amount & Project Period: | $250,000 (Direct Costs) - 5 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (X6071) |
| RFA Link: | RFA-MD-14-005 |
Lung Cancer
Research
Program (LCRP)
New
| Jul. 29 (Pre-app.) | All Ranks | Federal | Lung |
LCRP - Concept Award
The Concept Award supports highly innovative, untested, potentially groundbreaking concepts in lung cancer w/emphasis on innovation. Projects involving human subjects or human biological substances must be exempt or eligible for expedited review. Clinical trials not allowed. Preliminary data discouraged.| Due Date | July 29 (Pre-application) Applications Due: August 08 (OSR) | August 12 (Sponsor) |
| Amount & Project Period: | $100,000 (Direct Costs) -1 year |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| RFA Link: | W81XWH-14-LCRP-CA |
| July 29 (OSR) July 31 (Sponsor) |
Clinical/Postdoctoral Fellows & Faculty | Non-Federal | Cutaneous Lymphoma |
2014 CLARIONS Award Program - Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions
Innovative research in all areas of cutaneous lymphomas with particular interest in etiology and risk factors of cutaneous lymphomas, measures of disease impact on effected individuals and populations, translating discoveries into diagnostic and therapeutic advances, optimizing therapies and improving quality of life for individuals with cutaneous lymphomas.| Due Date | July 29 (OSR) | July 31 (Sponsor) |
| Amount & Project Period: | $25,000 for 1 year |
| Eligibility: | Investigators at all levels, from clinical and postdoctoral fellows to established investigators, are eligible to receive awards. Medical students and graduate students are not eligible. |
| Contact: | Linda Nolan, x6071 |
| Links: |
Research Awards Program CLARIONS Application Manual Grant Application |
New
| Jul. 30 (OSR)
Aug. 01 (Sponsor) |
Postdocs/Fellows | Non-federal | Career Development/Neurology |
Medical Education Research Training Fellowship
Priority given for plans evaluating educational outcomes impacting learning and medical practice change, population health outcomes, & patient quality or safety outcomes Intervention population may be medical students, residents, practicing physicians (i.e., CME), or inter-professional health care teams.| Due Date | July 30 (OSR)
| August 01 (Sponsor) |
| Amount & Project Period: | $65,000 - 1 year |
| Eligibility: | Must be an AAN member (Active or
Junior) embarking on a career in medical education research
who has completed a neurology, child neurology, or neuro-developmental
disabilities residency or neurology fellowship w/in the
past 5 years. |
| Contact: |
Linda Nolan
(x6071) |
| Links: |
Application Guidelines AAN Overview |
| R01 | NCI |
New
| Aug 03 | All Faculty | Federal | Mouse Models |
Collaborative Research Projects to Enhance Applicability of Mouse Models for Translational Research (Collaborative R01)
Applications sought from multi-disciplinary teams to expand, improve, or transform the utility of mouse cancer and tumor models for translational research.For a linked set of collaborative R01s, each site has its own Program Director(s)/Principal Investigator(s), and the program provides a mechanism for cross-site coordination and communication.
| Due Date: | July 31 (OSR) | August 03 (Sponsor) |
| Amount & Project Period: | $450,000/year (Direct Costs) - 3 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (X6071) |
| FOA Link: | PAR-14-240 |
| R01 | NCI |
New
| Aug. 03 | All Ranks | Federal | Mouse Models |
Research Projects to Enhance Applicability of Mouse Models for Translational Research (R01)
Applications to support projects devoted to overcoming limitations of mouse and human-in-mouse oncology models, defining a new translational use of models or mouse genetics for unmet needs, advancing standard practices for modeling human cancers and tumors in mice, and for validating and credentialing models, or develop widely applicable tool strains or resources that enable cross-species comparisons.| Due Date: | July 31 (OSR) | August 03 (Sponsor) |
| Amount & Project Period: | $450,000/year (Direct Costs ) - 3 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | PAR-14-241 |
| U24 | NCI |
New
| Jul 02 (LOI) Aug. 07 (Sponsor) |
All Faculty | Federal | Mouse Models |
Oncology Models Forum
To establish and maintain an "Oncology Models Forum" Focus is anticipated to be on effective, reliable use of mice, mouse models, and human-in-mouse models in translational cancer research, and other mouse modeling needs that the scientific community identifies.| Due Date: | July 02 (letter of Intent) Applications Due: August 05 (OSR) | August 07 (Sponsor) |
| Amount & Project Period: | $750,000/year (Direct Costs) - 5 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (X6071) |
| FOA Link: | PAR-14-239 |
New
| Aug. 11 (OSR) Aug. 13 (Sponsor) |
Postdocs/Jr. Faculty | Non-federal | Lung Cancer |
Uniting Against Lung Cancer (UALC) - Legacy Program
Seed money for promising and potentially transformative new projects. Interdisciplinary collaborations strongly encouraged. Does not require large amounts of preliminary data, but must have a clear hypothesis and research plan.| Due Date: | August 11 (OSR) | August 13 (Sponsor) |
| Amount & Project Period: | $50,000/year (Incl. 10% F&A)
- 2 years |
| Eligibility: | Hold a faculty appointment or be
mentored by a faculty member |
| Contact: |
Linda Nolan
(x6071) |
| RFA Links: |
Legacy Program (Guidelines) Uniting Against Lung Cancer (Funding Page) |
New
| Aug. 11 | Asst/Assoc members | Internal Funding | Career Development |
Moffitt Medical Group (MMG) Junior Faculty Team Research Award - Cycle I
Promotes exploration of innovative ideas and establishment of new collaborations.It is intended that the MMG Junior Faculty Team Research Award will be used for research directly related to cancer investigation and must be translational or clinical in nature. May request support for a clinical trial already been written; if so, a draft protocol and informed consent must be enclosed with application. MMG Junior Faculty Team Research Award may be awarded to investigators working with animal models, or to investigators using human tissue, fluid or blood samples for pre-clinical studies.
| Due Date | August 11 (Submitted as a single PDF file to Kim Murphy by 4:00pm) |
| Amount & Project Period: | $20,000 to $50,000 - 1 year |
| Eligibility: | Investigator must have completed the M.D. or PhD., be a member of the Moffitt Medical Group (MMG), and must have a track record of productivity. Those new to cancer research will receive priority. |
| Contact: | Kim Murphy (x1432) |
| RFA Link: | MMG Jr. Faculty Team Research Guidelines | Application |
Cycle 2
| Aug. 13 (OSR) Aug. 15 (Sponsor) |
Postdocs/Fellows | Non-federal | Career Development |
Damon Runyon Fellowship Award
Supports all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention| Due Date: | August 13 (OSR) | August 15 (Sponsor) |
| Amount & Project Period: | 3-year period Level 1: Stipend: $50,000/yr. Allowance: $2,000/yr Level 2: Stipend: $60,000/yr. Allowance: $2,000/yr. |
| Eligibility: | Level 1 Funding: Basic and physician-scientist
– degree received < 1 year prior to the Fellowship Award Committee (FAC) meeting when application is considered, and not have been in Sponsor's lab >1 year prior to meeting. Level 2 Funding: Physician-scientist applicant - (MD, MD/PhD, DDS, DVM or equiv.) must have completed residency & clinical training and be board-eligible in U.S. at award. Postdoctoral fellows, clinical fellows and clinical instructors are eligible. Foreign candidates may apply to do research only in U.S. |
| Contact: |
Linda Nolan (X6071) |
| Link: |
Fellowship Application Guidelines |
| August 1 (Pre-app)
August 13 (OSR) August 15 (Sponsor) |
Jr. Faculty | Federal | Breast Cancer |
Breast Cancer Research Program (BCRP) - Era of Hope Scholar Award
Central feature of the award is innovative contribution of Principal Investigator (PI) toward ending breast cancer. PI should articulate a vision challenging current dogma and demonstrating ability to look beyond tradition and convention.| Due Date: | August 1 (Pre-application) Applications Due: August 13 (OSR) | August 15 (Sponsor) |
| Amount & Project Period: | $2,500,000 direct costs for 5 years. |
| Eligibility: | Jr. Faculty: Independent investigator within 6 years of last training position. |
| Contact: | Linda Nolan, x6071 |
| PA Link: | W81XWH-14-BCRP-EOHS |
| August 11 (LOI)
Sept. 7 (OSR) Sept 11 (Sponsor) |
All Faculty | Federal | Radiation Dosing |
Decreasing Patient Radiation Dose from CT Imaging: Achieving Sub-mSv Studies
Research leading to reduction of patient radiation exposure from a routine CT scan to exposures <1 mSv.| Due Date: | August 11 (Letter of Intent)
Applications Due: September 07 (OSR) | September 11 (Sponsor) |
| Amount & Project Period: | Unlimited budget for 4 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan, x6071 |
| FOA Link: | PAR-12-206 |
| August 13 (OSR)
August 15 (Sponsor) |
All Ranks | Non-Federal | Pancreatic Cancer |
Hershberg Foundation for Pancreatic Cancer Research - Seed Grants
To provide start-up funding to test innovative ideas for improving diagnosis and to develop new treatment modalities in pancreatic cancer; obtain preliminary data required for additional funding impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy and to establish collaborations within the field.| Due Date: | August 13 (OSR) | August 15 (Sponsor) |
| Amount & Project Period: | $50,000 for 1 year (Renewable) |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | Seed Grants |
New
| Aug. 27 (Pre-app.) | Postdocs | Federal | Career Development |
Prostate Cancer Research Program Postdoctoral Training Award
Supports prostate cancer research training opportunities for recent doctoral graduates.| Due Date | August 27 (Pre-application)
Applications Due: September 08 (OSR) | September 10 (Sponsor) |
| Amount & Project Period: | $57,500/year (Direct Costs) - 2 years |
| Eligibility: | Postdocs |
| Contact: | Linda Nolan (x6071) |
| PA Link: | W81XWH-14-PCRP-PTA |
| Aug. 27 (Pre-app.) | Clinical fellows/Jr. Faculty | Federal | Career Development |
Prostate Cancer Research Program Physician Research Training Award
Supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. Emphasizes equally the quality of both the research and the training proposed.| Due Date | August 27 (Pre-application) Applications Due: September 08 (OSR) | September 10 (Sponsor) |
| Amount & Project Period: | $130,000/year (Direct Costs) - 4 years |
| Eligibility: | Must be a physician with clinical duties and/or responsibilities.
Must be in last year as resident/fellow or w/in 3 years of Jr. Faculty appt. |
| Contact: | Linda Nolan (x6071) |
| PA Link: |
W81XWH-14-PCRP-PRTA |
New
| Aug. 27 (OSR) Aug. 29 (Sponsor) |
Established Investigators | Non-federal | Gastric Cancer |
R. Robert & Sally Funderburg Research Award in Gastric Cancer
Novel approaches in gastric cancer research, including: gastric mucosal cell biology; regeneration and regulation of cell growth (not as related to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in diagnosis or treatment of gastric carcinoma.| Due Date | August 27 (OSR) | August 29 (Sponsor) |
| Amount & Project Period: | $50,000/year - 2 years |
| Eligibility: | Established Investigator in Gastric Biology AGA membership required at time of submission |
| Contact: | Linda Nolan, x6071 |
| RFA Link: | Research Award in Gastric Cancer |
New
| Sept. 11 (OSR) Sept. 15 (Sponsor) |
Postdocs | Non-federal | Career Development |
Sloan Research Fellowships
To stimulate fundamental research by early-career scientists and scholars of outstanding promise A program designed to stimulate fundamental research by early career scientists and scholars of outstanding promise.| Due Date | September 11 (OSR) | September 15 (Sponsor) |
| Amount & Project Period: |
$50,000 - 2 years
|
| Eligibility: |
|
| Contact: | Linda Nolan (x6071) |
| RFA Link: |
Sloan Research Fellowships |
New
| Sept 30 | All Faculty | Non-federal | Scientific Achievement |
National Foundation for Cancer Research
(NFCR)
2015 Szent-Györgyi Prize
Annual prize, in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, awarded to an outstanding researcher whose scientific achievements have
expanded understanding of cancer and whose discoveries have made possible new approaches to preventing, diagnosing, and/or treating cancer. | Due Date | Nominations Due: September 30 |
| Amount & Project Period: | $25,000 cash prize and recipient will lead the next Szent-Györgyi prize committee as honorary chair. |
| Eligibility: | Candidates must have made an original discovery or breakthrough in scientific understanding that has led to better prevention, earlier diagnosis, or new treatments for patients with cancer. |
| Contact: | Linda Nolan (x6071) |
| Links: |
2015 Szent-Györgyi Prize Nominations Call for Nominations National Foundation for Cancer Research |
Cycle 2
| Sept. 29 (OSR)
Oct. 01 (Sponsor) |
Postdocs | Non-federal | Immunology Career Development |
Irvington Post Doctoral Fellowships
Provides critical financial support and continued career training in cancer immunology| Due Date | September 29 (OSR) | October 01 (Sponsor) |
| Amount & Project Period: | 3 years - Stipend of
$50,000 Year 01 $53,000 Year 02 $57,000 Year 03 and $1,500/year for research support |
| Eligibility: | Must have doctoral degree by date of award activation. Applicants with 5 or more years of relevant postdoctoral experience are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. |
| Contact: | Linda
Nolan (X6071) |
| RFA Link: | Irvington Post Doctoral Fellowships |
Elsa U. Pardee Foundation
New
| Sept. 29 (OSR) Oct. 01 (Sponsor) |
All Ranks | Non-federal | Career Development |
Elsa U. Pardee Foundation Research Grants
Research directed toward identifying new treatments or cures for cancer, particularly encouraging applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.| Due Date |
September 29 (OSR) | October 01 (Sponsor) |
| Amount & Project Period: | Budgets are not limited - 1 year |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| RFA Link: |
Elsa U. Pardee Research Grants |
New
| Oct 13 (OSR) Oct 15 (Sponsor) |
PIs w/eligible grants | Federal | Dietary Supplements |
Research on Dietary Supplements (Admin. Supplement)
To support research where supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements.| Due Date | October 13 (OSR) | October 15 (Sponsor) |
| Amount & Project Period: | $100,000 (Total Costs) - Project and budget periods must be w/in currently approved project period for existing parent award |
| Eligibility: | All PIs w/eligible awards (see FOA) - For parent awards that include multiple PDs/PIs, supplement may be requested by any or all of the PDs/PIs (in accordance w/existing leadership plan) |
| Contact: | Linda Nolan (X6071) |
| FOA Link: |
PAR-14-201 |
Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts
RaceTracks
Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology
Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions
PubMed
National Cancer Institute
Clinical Research
Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
USF IRB
Liberty IRB
MRISignals@moffitt.org
